New York State Common Retirement Fund’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-10,110
| Closed | -$45.6K | – | 3238 |
|
|
2025
Q2 | $45.6K | Hold |
10,110
| – | – | ﹤0.01% | 2966 |
|
|
2025
Q1 | $44.8K | Hold |
10,110
| – | – | ﹤0.01% | 2815 |
|
|
2024
Q4 | $79.2K | Hold |
10,110
| – | – | ﹤0.01% | 2688 |
|
|
2024
Q3 | $133K | Sell |
10,110
-2,500
| -20% | -$31.7K | ﹤0.01% | 2469 |
|
|
2024
Q2 | $152K | Sell |
12,610
-3
| -0% | -$41 | ﹤0.01% | 2551 |
|
|
2024
Q1 | $205K | Buy |
12,613
+6,374
| +102% | +$85.9K | ﹤0.01% | 2426 |
|
|
2023
Q4 | $42.5K | Sell |
6,239
-31
| -0.5% | -$179 | ﹤0.01% | 3037 |
|
|
2023
Q3 | $34.2K | Buy |
6,270
+97
| +2% | +$565 | ﹤0.01% | 3108 |
|
|
2023
Q2 | $41.9K | Sell |
6,173
-52
| -0.8% | -$390 | ﹤0.01% | 3164 |
|
|
2023
Q1 | $31.2K | Sell |
6,225
-18,400
| -75% | -$75.1K | ﹤0.01% | 3067 |
|
|
2022
Q4 | $120K | Buy |
24,625
+10
| +0% | +$73 | ﹤0.01% | 2907 |
|
|
2022
Q3 | $355K | Buy |
24,615
+61
| +0.2% | +$1.01K | ﹤0.01% | 2506 |
|
|
2022
Q2 | $372K | Sell |
24,554
-25
| -0.1% | -$292 | ﹤0.01% | 2500 |
|
|
2022
Q1 | $292K | Sell |
24,579
-211,705
| -90% | -$2.17M | ﹤0.01% | 2658 |
|
|
2021
Q4 | $3.83M | Sell |
236,284
-65,714
| -22% | -$1.4M | ﹤0.01% | 1428 |
|
|
2021
Q3 | $8.62M | Buy |
301,998
+60,228
| +25% | +$1.9M | 0.01% | 1068 |
|
|
2021
Q2 | $8.17M | Buy |
241,770
+3,243
| +1% | +$104K | 0.01% | 1110 |
|
|
2021
Q1 | $7.21M | Buy |
238,527
+38,928
| +20% | +$1.6M | 0.01% | 1110 |
|
|
2020
Q4 | $9.88M | Buy |
199,599
+49,619
| +33% | +$2.3M | 0.01% | 951 |
|
|
2020
Q3 | $5.76M | Buy |
149,980
+23,202
| +18% | +$923K | 0.01% | 1110 |
|
|
2020
Q2 | $5.48M | Buy |
126,778
+6,700
| +6% | +$253K | 0.01% | 1134 |
|
|
2020
Q1 | $3.13M | Buy |
120,078
+99,278
| +477% | +$2.88M | ﹤0.01% | 1231 |
|
|
2019
Q4 | $650K | Hold |
20,800
| – | – | ﹤0.01% | 2159 |
|
|
2019
Q3 | $542K | Hold |
20,800
| – | – | ﹤0.01% | 2290 |
|
|
2019
Q2 | $476K | Buy |
20,800
+18,400
| +767% | +$423K | ﹤0.01% | 2400 |
|
|
2019
Q1 | $63K | Buy |
+2,400
| New | +$52.7K | ﹤0.01% | 3041 |
|
Other funds holding YMAB
New York State Common Retirement Fund's YMAB Position: Q3 2025 in Review
New York State Common Retirement Fund sold out of Y-mAbs Therapeutics (YMAB) in Q3 2025, closing a stake of 10,110 shares — an estimated $45.6K sold.
New York State Common Retirement Fund first reported a position in YMAB in Q1 2019 and held it in 26 quarters. The position peaked at $9.88M in Q4 2020. 2 funds tracked by Wall St. Rank hold YMAB as of Q3 2025.
- New York State Common Retirement Fund reported no remaining Y-mAbs Therapeutics position as of Q3 2025 after selling out during the quarter.
- New York State Common Retirement Fund sold 10,110 Y-mAbs Therapeutics shares in Q3 2025, an estimated $45.6K.
- New York State Common Retirement Fund first reported a position in Y-mAbs Therapeutics in Q1 2019 and held it in 26 quarters.
- New York State Common Retirement Fund's Y-mAbs Therapeutics position peaked at $9.88M in Q4 2020.
- 2 funds tracked by Wall St. Rank held Y-mAbs Therapeutics as of Q3 2025.
Based on New York State Common Retirement Fund's 13F filing for Q3 2025, filed 3 Nov 2025.